Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks

investors.com/news/technology/vertex-stock-vertex-pharmaceuticals-earnings-q1-2025

Vertex stock skidded Tuesday on a series of first-quarter setbacks that included light sales, slow uptake for two drugs and a paused study.
The post Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-05-06 14:31:03.
The Entire Business World on a Single Page. Free to Use →